AdvanSource Biomaterials Financials
We suggest to use AdvanSource Biomaterials fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if AdvanSource Biomaterials is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate thirty-one available fundamental indicators for AdvanSource Biomaterials, which can be compared to its peers.
AdvanSource |
Understanding current and past AdvanSource Biomaterials Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of AdvanSource Biomaterials' financial statements are interrelated, with each one affecting the others. For example, an increase in AdvanSource Biomaterials' assets may result in an increase in income on the income statement.
Please note, the presentation of AdvanSource Biomaterials' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AdvanSource Biomaterials' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of AdvanSource Biomaterials' management manipulating its earnings.
AdvanSource Biomaterials Stock Summary
AdvanSource Biomaterials competes with E Waste. Previously, the company was engaged in the development of polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. EKIMAS Corporation was incorporated in 1993 and is based in Las Vegas, Nevada. Ekimas Corp is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US28265K1060 |
| Business Address | 3651 Lindell Road, |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.advbiomaterials.com |
| Phone | 424 256 8560 |
| Currency | USD - US Dollar |
AdvanSource Biomaterials Key Financial Ratios
AdvanSource Biomaterials' financial ratios allow both analysts and investors to convert raw data from AdvanSource Biomaterials' financial statements into concise, actionable information that can be used to evaluate the performance of AdvanSource Biomaterials over time and compare it to other companies across industries.| Return On Equity | -51.46 | |||
| Return On Asset | -495.48 | |||
| Number Of Shares Shorted | 398 | |||
| Target Price | 2.0 | |||
| Beta | -0.43 |
AdvanSource Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AdvanSource Biomaterials's current stock value. Our valuation model uses many indicators to compare AdvanSource Biomaterials value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AdvanSource Biomaterials competition to find correlations between indicators driving AdvanSource Biomaterials's intrinsic value. More Info.AdvanSource Biomaterials is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AdvanSource Biomaterials by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AdvanSource Biomaterials' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Consideration for investing in AdvanSource Pink Sheet
If you are still planning to invest in AdvanSource Biomaterials check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AdvanSource Biomaterials' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |